Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$346,404,603
+$18,833,781 QoQ
Shares Held
1,376,588
-8.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#108
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. ABBV ranks #1 (34.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,404,603 | 1,376,588 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $327,570,822 | 1,506,142 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $309,432,125 | 1,354,248 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $346,585,279 | 1,496,870 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $252,174,793 | 1,358,554 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $169,510,269 | 809,041 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $145,431,100 | 818,408 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $181,241,218 | 917,770 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $159,418,747 | 929,447 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $177,493,233 | 974,702 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $173,587,008 | 1,120,133 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $175,593,870 | 1,178,008 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $172,335,298 | 1,279,116 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $213,591,337 | 1,340,223 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $220,677,807 | 1,365,496 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $198,516,451 | 1,479,148 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $218,082,070 | 1,423,884 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $255,406,897 | 1,575,516 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $227,267,680 | 1,678,491 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $189,869,968 | 1,760,174 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $200,529,500 | 1,780,269 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $223,417,484 | 2,064,475 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $230,268,671 | 2,149,031 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $183,098,048 | 2,090,399 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $206,123,116 | 2,099,441 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $164,527,351 | 2,159,435 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||